US2019203191A1PendingUtilityA1

Methods of recombinantly producing neutral protease originating from paenibacillus polymyxa

Assignee: ROCHE DIAGNOSTICS OPERATIONS INCPriority: Jul 9, 2012Filed: Mar 15, 2019Published: Jul 4, 2019
Est. expiryJul 9, 2032(~5.9 yrs left)· nominal 20-yr term from priority
C12Y 304/24C12N 5/0602C07K 14/195C12N 9/52C12N 2509/00C12Y 304/24028
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.

Claims

exact text as granted — not AI-modified
1 . A method for recombinantly producing a neutral protease, the method comprising the steps of
 (a) providing in an expression vector a DNA with a sequence encoding a preproenzyme according to SEQ ID NO:5, and transforming a host organism of the species  Bacillus amyloliquefaciens  with the expression vector, thereby obtaining a transformed host organism;   (b) expressing the DNA in the transformed host organism, wherein the transformed host organism secretes the neutral protease; and   (c) isolating the secreted neutral protease;   thereby recombinantly producing the neutral protease.   
     
     
         2 . The method according to  claim 1 , wherein the DNA comprises the sequence of position 34 to position 1896 of SEQ ID NO:6. 
     
     
         3 . The method according to  claim 1 , wherein step (b) comprises culturing the transformed host organism in a liquid medium, wherein the transformed host organism secretes the neutral protease into the liquid medium. 
     
     
         4 . The method according to  claim 3 , wherein step (c) comprises isolating the secreted neutral protease from the liquid medium. 
     
     
         5 . The method according to  claim 1 , wherein the host organism is deficient of an extracellular protease selected from Npr and Apr.

Join the waitlist — get patent alerts

Track US2019203191A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.